Science in motion

.NeuroRestore is a clinical treatment and research center, jointly operated by EPFL, CHUV and UNIL. We develop and translate neurotechnologies into clinical therapies. From the first experiment to the patient.

Scroll

We turn breakthroughs in neuroscience
into recovered movement.

We integrate implantable neurotechnologies and innovative treatments resulting from rigorous preclinical studies that have been conducted during the last 20 years in rodent and non-human primate models. These developments have led to breakthroughs for the treatment of paraplegia, tetraplegia, Parkinson’s disease, stroke, and traumatic brain injuries.

Key partners

  • CHUV
  • EPFL
  • UNIL

Our research areas

01

Spinal cord
injury

Targeted epidural stimulation reactivates the spinal cord below the injury and amplifies the commands still coming from the brain.

02

Parkinson's
disease

We decode brain and spinal dynamics during movement to correct the gait and balance deficits that medication leaves behind.

Fifteen years of preclinical research have produced implantable neurotechnologies

For paraplegia, tetraplegia, Parkinson's disease, stroke and traumatic brain injury.

0

Patients enrolled in clinical studies

0

Peer-reviewed publications

0

Years of translational research

0

International distinctions

Video unavailable. Place media/3D_BSI-2_Anim_Black_BG.mp4 next to this file.

Movement is a right,
not a privilege

  • Today it is a treatment, and the question has become how many people we can reach.

Rigorous preclinical studies

Every technology we bring to the clinic starts in our preclinical laboratories at EPFL. There, we map the neurons that produce movement, design the implants that engage them, and test their safety and precision before any use in humans. Our tools range from single-cell atlases of the spinal cord to soft implantable electrodes and computational models of the nervous system.

Preclinical laboratory work at NeuroRestore
EPFL preclinical laboratory Before any therapy reaches patients, it must be validated through rigorous preclinical research.
Rodent experiment in the NeuroRestore preclinical lab
Rodent models, first Animal experiments, starting with rodent models, are where these approaches are first tested.
Single-cell atlas of the spinal cord
Single-cell atlas of the spinal cord This foundational work lets us understand the mechanisms underlying neurological injury.
Preclinical study with Grégoire Courtine
Implants that engage movement neurons It also helps us understand the mechanisms of recovery.
Preclinical research session
Safety and precision, before any human use We test the safety and efficacy of new technologies under strictly controlled conditions.
Preclinical experiment at NeuroRestore
Controlled tests, then the clinic This step ensures our innovations translate into treatments that are scientifically sound and safe for clinical application.

The body is nature's
most complex circuit.
We learn to repair it.

Discover our publications

A human adventure

Around 20 million people worldwide have a spinal cord injury, which has a major impact on their quality of life. By disrupting electrical signals from the brain to the rest of the body, they can cause partial or complete paralysis.

Join a trial Support our research

Neuroscientists, neurosurgeons, engineers and physiotherapists working in the same building, on the same patients.

Meet the team

The NeuroRestore team

The paralysis is not
the end of the story